GBP2 facilitates the progression of glioma via regulation of KIF22/EGFR signaling

Identifying the mechanism of glioma progression is critical for diagnosis and treatment. Although studies have shown that guanylate-binding protein 2(GBP2) has critical roles in various cancers, its function in glioma is unclear. In this work, we demonstrate that GBP2 has high expression levels in g...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yeqing, Yang, Biao, Guo, Geng, Zhang, Jianping, Sun, Yanqi, Liu, Dong, Guo, Shihao, Wu, Yongqiang, Wang, Xiaogang, Wang, Shule, Zhang, Wenju, Guo, Xiaolong, Li, Xuepeng, Li, Ren, He, Jianhang, Zhou, Zihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016070/
https://www.ncbi.nlm.nih.gov/pubmed/35436989
http://dx.doi.org/10.1038/s41420-022-01018-0
Descripción
Sumario:Identifying the mechanism of glioma progression is critical for diagnosis and treatment. Although studies have shown that guanylate-binding protein 2(GBP2) has critical roles in various cancers, its function in glioma is unclear. In this work, we demonstrate that GBP2 has high expression levels in glioma tissues. In glioma cells, depletion of GBP2 impairs proliferation and migration, whereas overexpression of GBP2 enhances proliferation and migration. Regarding the mechanism, we clarify that epidermal growth factor receptor (EGFR) signaling is regulated by GBP2, and also demonstrate that GBP2 interacts directly with kinesin family member 22(KIF22) and regulates glioma progression through KIF22/EGFR signaling in vitro and in vivo. Therefore, our study provides new insight into glioma progression and paves the way for advances in glioma treatment.

Ejemplares similares